Stage 1 Results of BrUOG 354: A Randomized Phase II Trial of Nivolumab Alone or in Combination with Ipilimumab for People with Ovarian and Other Extra-Renal Clear Cell Carcinomas (NCT03355976).
Journal of Clinical Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined